Literature DB >> 2930664

Electrophysiological study of young patients with exercise related paroxysms of palpitation: role of atropine and isoprenaline for initiation of supraventricular tachycardia.

I Toda1, T Kawahara, Y Murakawa, A Nozaki, K Kawakubo, H Inoue, T Sugimoto.   

Abstract

Electrophysiological studies were performed in eight patients (four men and four women, mean (SD) age 24 (5) years with paroxysmal attacks of palpitation during or immediately after exercise. Five patients were competitive athletes at college. In two patients spontaneous supraventricular tachycardia during exercise was recorded by ambulatory electrocardiographic monitoring and in another it was induced by treadmill exercise testing. Two had dual atrioventricular nodal pathways, three had manifest atrioventricular accessory pathways, and three had concealed atrioventricular pathways. Programmed stimulation induced sustained supraventricular tachycardia in six patients--in two after intravenous injection of atropine sulphate (1 mg) and in four during infusion of isoprenaline (0.01 microgram/kg/min). In one patient, non-sustained atrioventricular nodal reentrant tachycardia was induced during isoprenaline infusion. In the remaining patient, who had dual atrioventricular nodal pathways, tachycardia was not inducible. AH block prevented maintenance of reentry in five patients. In five patients shortening of the effective refractory period of the atrioventricular node with atropine (one patient) and isoprenaline (four patients) caused sustained supraventricular tachycardia. The present study indicates that treatment with atropine and isoprenaline may be an important factor in the initiation of supraventricular tachycardia in patients with exercise related paroxysms of palpitation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2930664      PMCID: PMC1216656          DOI: 10.1136/hrt.61.3.268

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  14 in total

1.  Exercise and arrhythmia.

Authors:  M Murayama; K Shimomura
Journal:  Jpn Circ J       Date:  1979-03

2.  Electrocardiogram of the athlete. Alterations simulating those of organic heart disease.

Authors:  J Lichtman; R A O'Rourke; A Klein; J S Karliner
Journal:  Arch Intern Med       Date:  1973-11

3.  The effects of cycle length on cardiac refractory periods in man.

Authors:  P Denes; D Wu; R Dhingra; R J Pietras; K M Rosen
Journal:  Circulation       Date:  1974-01       Impact factor: 29.690

4.  Cardiac arrhythmias observed during maximal treadmill exercise testing in clinically normal men.

Authors:  P L McHenry; C Fisch; J W Jordan; B R Corya
Journal:  Am J Cardiol       Date:  1972-03       Impact factor: 2.778

5.  In vivo validation of the origin of the esophageal electrocardiogram.

Authors:  P F Binkley; C A Bush; B L Fleishman; C V Leier
Journal:  J Am Coll Cardiol       Date:  1986-04       Impact factor: 24.094

6.  Twenty-four hour continuous ECG recordings in long-distance runners.

Authors:  D A Talan; R A Bauernfeind; W W Ashley; C Kanakis; K M Rosen
Journal:  Chest       Date:  1982-07       Impact factor: 9.410

7.  Treadmill exercise testing in the Wolff-Parkinson-White syndrome.

Authors:  B Strasberg; W W Ashley; C R Wyndham; R A Bauernfeind; S P Swiryn; R C Dhingra; K M Rosen
Journal:  Am J Cardiol       Date:  1980-04       Impact factor: 2.778

8.  Tachyarrhythmias in young athletes.

Authors:  A Coelho; E Palileo; W Ashley; S Swiryn; A T Petropoulos; W J Welch; R A Bauernfeind
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

9.  Effects of isoproterenol and amiodarone and the role of exercise in initiation of circus movement tachycardia in the accessory atrioventricular pathway.

Authors:  P Brugada; M Facchini; H J Wellens
Journal:  Am J Cardiol       Date:  1986-01-01       Impact factor: 2.778

10.  Exercise provocation of multiple reentrant tachycardias in a patient with permanent form of junctional tachycardia and intermittent ventricular preexcitation.

Authors:  S J Yeh; F C Lin; D Wu
Journal:  Am Heart J       Date:  1986-11       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.